For general information only. Not a substitute for professional medical advice.
Medi Info Hub Logo
Educational Medication GuidePrescriptionClass: Direct Factor Xa Inhibitor (DOAC)

Xarelto

Generic Name: Rivaroxaban

Common Brand Names: Xarelto
Dosage Form:Oral Tablets, Oral Suspension
Route:Oral
Pregnancy Category:Category C
Last Reviewed:9/21/2026

Uses & Medical Indications

Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation; treatment of DVT and PE.

Medical Conditions Treated:

Deep Vein Thrombosis, Pulmonary Embolism, Nonvalvular Atrial Fibrillation

Work Mechanism & Pharmacology

How It Works

Patient Overview of Work Mechanism

Xarelto works at the cellular level to correct underlying biochemical imbalances, reduce clinical symptoms, and support overall health.

Clinical Mechanism of Action (MoA)

Xarelto exerts targeted therapeutic activity by interacting with specific cellular receptors, enzymatic pathways, or biological signaling cascades to relieve symptoms and restore physiological balance.

Primary TargetRivaroxaban
Therapeutic FamilyAnticoagulant
Administration RouteOral

Dosage & Administration Guidelines

Adult Dosage

20 mg orally once daily with the evening meal for AFib; 15 mg twice daily with food for 21 days for acute DVT/PE followed by 20 mg once daily.

Pediatric Dosage

Specialized weight-based dosing for pediatric venous thromboembolism.

Elderly / Geriatric Considerations

No adjustment needed based purely on age; dose according to renal clearance.

Maximum Dose Limit

20 mg daily.

Renal Impairment:

Avoid if CrCl <15 mL/min. Reduce to 15 mg daily for AFib if CrCl 15-50 mL/min.

Hepatic Impairment:

Avoid in patients with moderate to severe hepatic impairment (Child-Pugh B and C).

Side Effects & Safety Warnings

Common Side Effects

Bleeding complications (epistaxis, hematoma, hematuria), abdominal pain, dizziness.

Serious Adverse Reactions

Epidural/spinal hematoma, intracranial hemorrhage, fatal bleeding.

Contraindications:

Active pathological bleeding, significant hypersensitivity.

Important Warnings & Precautions:

Black Box Warning: Premature discontinuation increases thrombotic event risk; epidural anesthesia risk.

Interactions (Drugs, Food & Alcohol)

Drug-Drug Interactions:

Combined P-gp and strong CYP3A4 inhibitors (ketoconazole, ritonavir) or inducers (rifampin, carbamazepine).

Food & Dietary Interactions:

15 mg and 20 mg tablets MUST be taken with food to ensure adequate bioavailability.

Alcohol Interaction Warning:

Moderate to heavy drinking increases bleeding danger.

Pregnancy & Breastfeeding Safety

Pregnancy Safety

Avoid during pregnancy due to intrinsic bleeding hazard for mother and fetus.

Breastfeeding / Lactation

Excreted in milk; decide between nursing or medication continuation.

Patient Counseling & Practical Advice

How to Take:

Always take with your evening meal. Report any signs of internal bleeding or black stools.

What to Do if You Miss a Dose:

Take as soon as remembered on the same day. Do not double doses.

Recommended Monitoring & Lab Tests:

Renal function tests, complete blood count, signs of bleeding.

Emergency Medical Warning

When to Seek Urgent Medical Attention

Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.

Emergency Safety Protocol: If an intentional or accidental overdose is suspected, contact your regional Poison Control Center or emergency services immediately. Do not induce vomiting unless strictly advised by emergency healthcare personnel.
Educational Sources & References

Content for Xarelto was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:

  • Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
  • World Health Organization (WHO) — Model List of Essential Medicines
  • Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
  • National Health Service (NHS) — Medicines A to Z Clinical Guidelines
Published by: Medi Info Hub TeamLast Updated: 10/19/2026

The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.